methylprednisolone acetate has been researched along with Clinically Isolated CNS Demyelinating Syndrome in 2 studies
Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.
Excerpt | Relevance | Reference |
---|---|---|
"Clinical trials first began in 1960 with methylprednisolone acetate (Depo-Medrol) administered intrathecally, in an attempt to treat both disk disease and multiple sclerosis." | 4.77 | Dangers from methylprednisolone acetate therapy by intraspinal injection. ( Nelson, DA, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Almalki, DM | 1 |
Mudhafar, OY | 1 |
Alsaman, AS | 1 |
Mahmoud, AA | 1 |
Nelson, DA | 1 |
1 review available for methylprednisolone acetate and Clinically Isolated CNS Demyelinating Syndrome
Article | Year |
---|---|
Dangers from methylprednisolone acetate therapy by intraspinal injection.
Topics: Demyelinating Diseases; Humans; Injections, Epidural; Injections, Spinal; Intervertebral Disc; Methy | 1988 |
1 other study available for methylprednisolone acetate and Clinically Isolated CNS Demyelinating Syndrome
Article | Year |
---|---|
Diagnostic uncertainty of tumefactive cystic demyelinating lesions.
Topics: Brain; Child; Demyelinating Diseases; Female; Glucocorticoids; Humans; Magnetic Resonance Imaging; M | 2013 |